1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-75100
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-75104
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-1495, E1495
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: ECOG-2496, CAN-NCIC-HD7, CALGB-59905, SWOG-E2496, E2496, NCT00003389, HD7
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and under
Sponsor: NCI
Protocol IDs: POG-7621
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-340
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 60
Sponsor: Other
Protocol IDs: BNLI-STANFORDV, EU-20206, NCT00041210
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7406, MDAR-117
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7518, MDAR-24
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-774/775
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 18
Sponsor:
Protocol IDs: WCG-130
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 61
Sponsor:
Protocol IDs: WCG-135
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: CCG-541, CLB-7691, POG-7660
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDAR-37
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-RT-8001
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI
Protocol IDs: POG-7909
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 65
Sponsor:
Protocol IDs: NCI-78-C-34, NCI-MB-93
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: NCI-78-C-56, NCI-NMOB-814
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: CLB-8251, CALGB-8251
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 14 and over
Sponsor: NCI
Protocol IDs: BRMP-8904, UMCC-7824, NCI-79-C-143, NCI-MB-133, NCI-MB-ROB-133, NCI-T83-1467N, T83-1467
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: BRMP-8903, NCI-78-C-145, NCI-MB-110, NCI-N82-522, N82-0522
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-79-C-70, NCI-NMOB-816, NCI-T83-1451N, NCI-N81-900, N81-0900
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: NCI-81-C-166A, NCI-MB-161, NCI-T84-0248N, T84-0248
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-8914, NCI-81-C-178, NCI-MB-166, NCI-T83-0977N, T83-0977
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor:
Protocol IDs: NCI-78-C-118, UMCC-7808, NCI-MB-114, NCI-T83-0983, T83-0983
|
